More on MEDS

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)
- Dividends

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

TRxADE HEALTH (NQ:MEDS)
Delayed: 2.63 -0.22 (7.72%)
Prev. Close $2.85  
Open$2.80 
52 Wk High$2.80 
52 Wk Low$0.08 
Day High$2.86 
Day Low$2.62 
P/E N/A  
EPS$0.00 
Volume309,266 

Friends, Peers and Foes (?): DVLT, WGRX, AGPU, SCLX, KOD (more...)

Oct 16, 2026 05:15 PM Form 8-K DataMeds AI, Inc. For: Oct 13
Oct 16, 2026 06:03 AM DataMeds outlines peptide compounding plans after FDA policy proposal
Oct 16, 2026 06:01 AM DataMeds Applauds FDA's Proposed Interim Access Policy for Compounding Using Certain Peptides and Provides Corexa Health's Peptides Roadmap
Oct 14, 2026 09:48 AM DataMeds AI licenses Reboot Health AI's GLP-1 care platform for U.S. use
Oct 14, 2026 09:48 AM DataMEDS Si Licenses U.S. Rights To Reboot Health AI's Direct-To-Consumer GLP-1 Weight Management Platform
Oct 13, 2026 05:27 PM Form 8-K DataMeds AI, Inc. For: Oct 13
Oct 13, 2026 12:48 PM Form PRE 14C DataMeds AI, Inc. For: Oct 09
Oct 13, 2026 06:03 AM DataMeds AI cuts staff, refocuses on ChemoFx cancer diagnostic test
Oct 13, 2026 06:01 AM DataMEDS SI Provides Business Update On CLIA Lab Helomics And Its Super Intelligence Predictive Oncology Division
Oct 12, 2026 06:02 AM Humana Medicaid covers Helomics ChemoFx assay for gynecologic cancers
View All Articles

Entities mentioned with MEDS

View All Entities